Sean P. Brusky
Corporate Officer/Principal bei PARDES BIOSCIENCES, INC.
Profil
Sean P.
Brusky is currently the Chief Commercial Officer at Pardes Biosciences, Inc. He previously worked as the Head of Healthcare Delivery Innovation at Genentech, Inc. and as a Manager of Business and Corporate Development at Vertex Pharmaceuticals, Inc. He received his undergraduate degree from Brown University and his MBA from Harvard Business School.
Aktive Positionen von Sean P. Brusky
Unternehmen | Position | Beginn |
---|---|---|
PARDES BIOSCIENCES, INC. | Corporate Officer/Principal | 01.05.2021 |
Ehemalige bekannte Positionen von Sean P. Brusky
Unternehmen | Position | Ende |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.08.2004 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Sean P. Brusky
Brown University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
Private Unternehmen | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Pardes Biosciences, Inc.
Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |